Navigation Links
Ardea Biosciences Establishes Scientific Advisory Board for HIV Program
Date:2/4/2008

University of Alabama at Birmingham, where he is also Professor of Medicine. He currently is on the Board of Directors of the American Board of Internal Medicine and of the International AIDS Society-USA, and is President-elect of the HIV Medical Association. Dr. Saag created a comprehensive HIV outpatient clinic, has published over 200 articles in peer reviewed journals and contributed over 50 chapters to medical textbooks.

Robert Schooley, MD, is Professor and Head of the Division of Infectious Diseases of the University of California, San Diego. He has served as Chair of the National Institutes of Health's AIDS and Related Retrovirus 1 Study Section and as Chair of the Executive Committee of the National Institute of Allergy and Infectious Diseases, Adult Clinical Trials Group (ACTG).

About Ardea Biosciences, Inc.

Ardea Biosciences of Carlsbad, California is a biotechnology company focused on the discovery and development of small-molecule therapeutics in virology, oncology and inflammation. The Company has two product candidates in clinical development and several others in preclinical development. Ardea's most advanced clinical development candidate is RDEA806, a non-nucleoside reverse transcriptase inhibitor (NNRTI), which is in a Phase 2a study for the treatment of HIV. In addition, the Company is also investigating RDEA806 for the treatment of gout. In oncology, the Company is investigating a mitogen-activated ERK kinase (MEK) inhibitor, RDEA119, in a Phase 1 study in advanced cancer patients. Ardea also is developing a next-generation NNRTI for HIV and a next-generation MEK inhibitor for both cancer and inflammatory diseases.

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from th
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
2. Ardea Biosciences Announces Changes to Research Management
3. Ardea Biosciences, Inc. Reports Third Quarter 2007 Operating and Financial Results
4. Ardea Biosciences to Participate in RBC Capital Markets 2007 Healthcare Conference
5. Ardea Biosciences Announces $40 Million Private Placement
6. Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
9. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
10. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
11. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... July 28, 2015  PDL BioPharma, Inc. (PDL, or ... the Company will release its second quarter 2015 financial ... Wednesday, August 5, 2015, after market close. PDL,s management ... at 4:30 p.m. Eastern Time to discuss the financial ... be available via the webcast link on the PDL ...
(Date:7/28/2015)... BILLERICA, Mass. , July 28, 2015 /PRNewswire/ ... for measuring cell metabolism, is the provider of ... utilized across all disease research areas. As the ... revealed, exploration into cell metabolism is escalating rapidly.   ... been published by the Nature Publishing Group (NPG) ...
(Date:7/28/2015)... -- Research and Markets ( ... "Analysis of the Global Flow Cytometry Market ... Globally, flow cytometry remains a popular tool for ... stem cells. But the market is witnessing active ... from underdeveloped nations to quantitate CD4 cell markers ...
(Date:7/28/2015)... ... July 28, 2015 , ... VetStem Biopharma will be offering ... credentialing course to local area veterinarians. , The tour and course will be given ... no charge) at VetStem’s Poway facility. Staff members are welcome to attend with their ...
Breaking Biology Technology:PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2XF Technology Used to Demonstrate Feasibility of Stem Cell Regenerative Technique 2XF Technology Used to Demonstrate Feasibility of Stem Cell Regenerative Technique 3Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour 2
... Calif., Aug. 2 Beckman Coulter, Inc. (NYSE: ... that simplify, automate and innovate complex biomedical testing, announced today ... This acquisition, first announced in February, extends Beckman Coulter,s ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ...
... Brussels - Numerous pathogens contain an ,internal time bomb, a ... of work, VIB researchers at the Vrije Universiteit Brussel (VUB) ... the proteins involved. This clears the road for finding ways ... hopefully, in the process developing a new class of ...
... SAN MATEO, Calif., July 31 NeurogesX, Inc. (Nasdaq: ... novel pain management therapies, today announced it will hold a conference ... a.m. PT) to report results for its second quarter 2009. ... by Anthony DiTonno, President and Chief Executive Officer, and Stephen Ghiglieri, ...
Cached Biology Technology:Beckman Coulter Completes Acquisition of Olympus' Lab-Based Diagnostics Business 2Bacteria pack their own demise 2Bacteria pack their own demise 3NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results 2NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results 3
(Date:7/21/2015)... , July 21, 2015 Passwords ... as seen in the recent U.S. Office of ... solution to the infosec conundrum, but developers and ... stored. To address this dilemma, Biometrics-as-a-Service provider HYPR ... Biometric Tokenization SDK for third party integration. ...
(Date:7/9/2015)... July 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), ... that it will report financial results for the fourth ... 2015 after the close of market. The company will ... at 2:00 p.m. PT (5:00 p.m. ET), during which ... participate on the live call, analysts and investors should ...
(Date:7/8/2015)... NEW YORK , July 8, 2015 ... cancer globally, and the fourth most fatal, with a ... year. The poor prognosis of pancreatic cancer patients has ... to treatment, which is not being met by the ... contains an array of products with varying molecule types ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... the arrival of the first plants 470 million years ago triggered ... and Oxford, the study is published today (1 February 2012) in ... the effects that the first land plants had on the climate ... this period the climate gradually cooled, leading to a series of ...
... HOUSTON (Jan. 31, 2012) Just the mention of ... often painful and sometimes difficult to remove, and 10 percent ... risk of developing kidney stones is exacerbated due to environmental ... resource limitations and distance from Earth could restrict treatment options. ...
... past 30 years, numerous studies have linked Borna disease ... schizophrenia, anxiety disorder and dementia. Genetic fragments and antibodies ... a range of mammals and birds, have been found ... have been inconsistent. Now, the first blinded, case-control ...
Cached Biology News:First plants caused ice ages 2Twinkle, twinkle kidney stone: With a push you could be gone 2Twinkle, twinkle kidney stone: With a push you could be gone 3Does Borna disease virus cause mental illness? 2
Rat Antibody to Kinase Suppressor Of Ras Recognises the kinase suppressor of Ras (KSR). Immunogen: Recombinant human KSR protein Specificity: human kinase supressor of Ras...
KNP-1 (HES1) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 35, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details....
... clone E978 GenBank ... Immunogen : NY-ESO-1 ... mouse ascites with 0.05% ... routinely evaluated by immunoblot ...
NATIVE RAT OSTEOCALCIN...
Biology Products: